Purpose: Autologous Matrix-Induced Chondrogenesis (AMIC) utilizing a type I/III collagen membrane was compared with microfracture (MFx) alone in focal cartilage lesions of the knee at one, two and five years.
Methods: Forty-seven patients (aged 37 ± 10 years, mean defect size 3.6 ± 1.6 cm) were randomized and treated either with MFx, with sutured or glued AMIC in a prospective multicentre clinical trial.
Results: After improvement for the first two years in all subgroups, a progressive and significant score degradation was observed in the MFx group, while all functional parameters remained stable for least five years in the AMIC groups. At two and five years, MRI defect filling was more complete in the AMIC groups. No treatment-related adverse events were reported.
Conclusions: AMIC is an effective cartilage repair procedure in the knee resulting in stable clinical results significantly better than the MFx group at five years.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00264-016-3391-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Results after Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A 10-Year Cohort Study.
Cartilage
December 2024
Center for Foot and Ankle Surgery, Schön Klinik München Harlaching-FIFA Medical Centre of Excellence, Munich, Germany.
Objective: A gold standard surgical treatment for osteochondral lesions (OCLs) of the talus still needs to be established. Still, autologous matrix-induced chondrogenesis (AMIC) is a commonly applied 1-stage procedure that has achieved good short- and mid-term results. The present cohort study aimed to assess whether the long-term, 10-year results can confirm the previous findings.
View Article and Find Full Text PDFOperative Treatment of Nonprimary Osteochondral Lesions of the Talus: A Systematic Review.
Orthop J Sports Med
December 2024
Clínica Espregueira - FIFA Medical Centre of Excellence, Porto, Portugal.
Background: Nonprimary osteochondral lesions of the talus (OLT) pose a significant challenge in orthopaedics, with no definitive consensus on optimal surgical treatment.
Purpose: To consolidate the most recent evidence on operative treatments for nonprimary OLT by assessing patient-reported outcomes (PROs), postoperative complications, and clinical failures.
Study Design: Systematic review; Level of evidence, 4.
Hydrogel-Enhanced Autologous Chondrocyte Implantation for Cartilage Regeneration-An Update on Preclinical Studies.
Bioengineering (Basel)
November 2024
Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA.
Autologous chondrocyte implantation (ACI) and matrix-induced ACI (MACI) have demonstrated improved clinical outcomes and reduced revision rates for treating osteochondral and chondral defects. However, their ability to achieve lasting, fully functional repair remains limited. To overcome these challenges, scaffold-enhanced ACI, particularly utilizing hydrogel-based biomaterials, has emerged as an innovative strategy.
View Article and Find Full Text PDFComparison of autologous matrix-induced chondrogenesis and mosaicplasty in the treatment of osteochondral defects of the talus.
Acta Orthop Traumatol Turc
November 2024
Department of Orthopaedics and Traumatology, Acıbadem Eskişehir Hospital, Eskişehir, Türkiye.
Article Synopsis
- - The study compared the long-term effectiveness of two treatment methods, mosaicplasty and autologous matrix-induced chondrogenesis (AMIC), for osteochondral defects in the talus, evaluating 50 patients over a decade.
- - Both treatment groups showed significant improvements in functional scores post-surgery, though AMIC had slightly better outcomes; factors like age and gender did not impact effectiveness.
- - The researchers concluded that both methods are effective, but AMIC may offer superior results for similarly sized defects with less risk of complications compared to mosaicplasty.
Autologous chondrocyte implantation, matrix-induced autologous chondrocyte implantation, osteochondral autograft transplantation and osteochondral allograft improve knee function and pain with considerations for patient and cartilage defects characteristics: A systematic review and meta-analysis.
Knee Surg Sports Traumatol Arthrosc
November 2024
Department of Orthopedic Surgery, Twin Cities Orthopedics, Edina, Minnesota, USA.
Purpose: Previous studies have reported on the outcomes of autologous chondrocyte implantation (ACI) versus matrix-induced ACI (MACI) and microfracture. Specific clinical outcomes of ACI, MACI, osteochondral autograft transplantation (OAT) and osteochondral allograft (OCA) have not been well studied. The purpose of this systematic review and meta-analysis was to analyze the outcomes of these regenerative surgical techniques with an emphasis on comparing their effectiveness using the International Knee Documentation Committee (IKDC) subjective score, the Lysholm Knee Scoring Scale, the Tegner Activity Scale and the Visual Analogue Scale (VAS) score for the surgical treatment of tibiofemoral joint cartilage defects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!